{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T19:19:51Z","timestamp":1782587991153,"version":"3.54.5"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.atherosclerosis.2023.117305","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T05:53:29Z","timestamp":1696917209000},"page":"117305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Long-term outcomes of liver transplantation for homozygous familial hypercholesterolaemia in Australia and New Zealand"],"prefix":"10.1016","volume":"387","author":[{"given":"Michael M.","family":"Page","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winita","family":"Hardikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Alex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubha","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stormon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kat","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Wigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libby","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif I.","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117305_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11883-018-0731-0","article-title":"The present and the future of genetic testing in familial hypercholesterolemia: opportunities and caveats","volume":"20","author":"Hooper","year":"2018","journal-title":"Curr. Atherosclerosis Rep."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117305_bib2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.hlc.2020.09.943","article-title":"Integrated guidance for enhancing the care of familial hypercholesterolaemia in Australia","volume":"30","author":"Watts","year":"2021","journal-title":"Heart Lung Circ."},{"issue":"22","key":"10.1016\/j.atherosclerosis.2023.117305_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11226638","article-title":"New trends and therapies for familial hypercholesterolemia","volume":"11","author":"Alnouri","year":"2022","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117305_bib4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/MOL.0000000000000784","article-title":"Use of apheresis in the age of new therapies for familial hypercholesterolaemia","volume":"32","author":"Thompson","year":"2021","journal-title":"Curr. Opin. Lipidol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2023.117305_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11883-019-0787-5","article-title":"Current role of lipoprotein apheresis","volume":"21","author":"Thompson","year":"2019","journal-title":"Curr. Atherosclerosis Rep."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117305_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacl.2011.03.001","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"J Clin Lipidol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2023.117305_bib7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5551\/jat.CR003","article-title":"Guidelines for diagnosis and treatment of familial hypercholesterolemia 2017","volume":"25","author":"Harada-Shiba","year":"2018","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.atherosclerosis.2016.10.017","article-title":"HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom","volume":"255","author":"France","year":"2016","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117305_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijcard.2013.11.025","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation","volume":"171","author":"Watts","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"26","key":"10.1016\/j.atherosclerosis.2023.117305_bib10","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1056\/NEJM198412273112603","article-title":"Liver transplantation to provide low-density lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia","volume":"311","author":"Bilheimer","year":"1984","journal-title":"N. Engl. J. Med."},{"issue":"10326","key":"10.1016\/j.atherosclerosis.2023.117305_bib11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(21)02001-8","article-title":"Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study","volume":"399","author":"Tromp","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2023.117305_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029175","article-title":"Contemporary homozygous familial hypercholesterolemia in the United States: insights from the CASCADE FH Registry","volume":"12","author":"Cuchel","year":"2023","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117305_bib13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/imj.12444","article-title":"Liver transplantation for the treatment of homozygous familial hypercholesterolaemia in an era of emerging lipid-lowering therapies","volume":"44","author":"Page","year":"2014","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1440-0960.2004.00103.x","article-title":"Homozygous familial hypercholesterolaemia presenting with cutaneous xanthomas: response to liver transplantation","volume":"45","author":"Moyle","year":"2004","journal-title":"Australas. J. Dermatol."},{"issue":"25","key":"10.1016\/j.atherosclerosis.2023.117305_bib15","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/eurheartj\/ehad197","article-title":"Update on European atherosclerosis society consensus statement on homozygous familial hypercholesterolaemia: new treatments and clinical guidance","volume":"44","author":"Cuchel","year":"2023","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117305_bib16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0021-9150(00)00371-3","article-title":"The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels","volume":"152","author":"Kroon","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib17","series-title":"36-Item Short Form Survey from the RAND Medical Outcomes Study","year":"2012"},{"issue":"8391","key":"10.1016\/j.atherosclerosis.2023.117305_bib18","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0140-6736(84)91876-2","article-title":"Heart-liver transplantation in a patient with familial hypercholesterolaemia","author":"Starzl","year":"1984","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117305_bib19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0002-9149(87)91199-4","article-title":"Liver transplantation for treatment of cardiovascular disease: comparison with medication and plasma exchange in homozygous familial hypercholesterolemia","volume":"59","author":"Hoeg","year":"1987","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117305_bib20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00007890-199302000-00037","article-title":"Liver transplantation for familial hypercholesterolemia before the onset of cardiovascular complications","volume":"55","author":"Sokal","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0041-1345(02)03910-6","article-title":"Long-term outcome of liver transplantation for familial hypercholesterolemia","volume":"35","author":"Shrotri","year":"2003","journal-title":"Transplant. Proc."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117305_bib22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1053\/jpsu.2000.0350630","article-title":"Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass","volume":"35","author":"Lopez-Santamaria","year":"2000","journal-title":"J. Pediatr. Surg."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117305_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5551\/jat.14.94","article-title":"Long-term outcome after living donor liver transplantation for two cases of homozygous familial hypercholesterolemia from a heterozygous donor","volume":"14","author":"Kawagishi","year":"2007","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/lt.22443","article-title":"Domino liver transplantation: how far can we push the paradigm?","volume":"18","author":"Popescu","year":"2012","journal-title":"Liver Transplant."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-0012.2001.150612.x","article-title":"Plasma exchange and heart-liver transplantation in a patient with homozygous familial hypercholesterolemia","volume":"15","author":"Offstad","year":"2001","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1399-3046.2010.01469.x","article-title":"Liver transplantation as a treatment option for three siblings with homozygous familial hypercholesterolemia","volume":"15","author":"K\u00fc\u00e7\u00fckkartallar","year":"2011","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib27","first-page":"E25","article-title":"Preemptive liver transplantation in a child with familial hypercholesterolemia","volume":"15","author":"Maiorana","year":"2010","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib28","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00147-004-0791-7","article-title":"Successful living-related liver transplantation for familial hypercholesterolemia in the Middle East","volume":"17","author":"Khalifeh","year":"2005","journal-title":"Transpl. Int."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1399-0012.2007.00764.x","article-title":"Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL-receptor gene mutation","volume":"22","author":"Schmidt","year":"2008","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib30","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.transproceed.2009.07.028","article-title":"Liver transplantation for homozygous familial hypercholesterolemia: two case reports","volume":"41","author":"Kakaei","year":"2009","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12265-011-9311-1","article-title":"Translational lessons from a case of combined heart and liver transplantation for familial hypercholesterolemia 20 years post-operatively","volume":"5","author":"Ibrahim","year":"2012","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib32","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1111\/j.1399-3046.2009.01133.x","article-title":"Domino liver graft from a patient with homozygous familial hypercholesterolemia","volume":"14","author":"Liu","year":"2010","journal-title":"Pediatr. Transplant."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117305_bib33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.7326\/0003-4819-108-2-204","article-title":"Lipids and lipoprotein changes after heart and liver transplantation in a patient with homozygous familial hypercholesterolemia","volume":"108","author":"Valdivielso","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib34","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.transproceed.2007.07.068","article-title":"Combined cardiohepatic transplantation due to severe heterozygous familial hypercholesteremia Type II: first case in Argentina - a case report","volume":"39","author":"Ahualli","year":"2007","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib35","article-title":"Homozygous familial hypercholesterolemia: case series and review of the literature","volume":"2011","author":"Palacio","year":"2011","journal-title":"Case Rep Transplant"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2023.117305_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13730","article-title":"The curative treatment of familial hypercholesterolemia: liver transplantation","volume":"33","author":"Gulsoy Kirnap","year":"2019","journal-title":"Clin. Transplant."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117305_bib37","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.amjcard.2016.05.042","article-title":"Effects of liver transplantation on lipids and cardiovascular disease in children with homozygous familial hypercholesterolemia","volume":"118","author":"Martinez","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.567895","article-title":"Case report: liver transplantation in homozygous familial hypercholesterolemia (HoFH)-long-term follow-up of a patient and literature review","volume":"8","author":"Mlinaric","year":"2020","journal-title":"Front Pediatr"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2023.117305_bib39","article-title":"Perioperative management and clinical outcomes of liver transplantation for children with homozygous familial hypercholesterolemia","volume":"58","author":"Qiu","year":"2022","journal-title":"Medicina (Kaunas)."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117305_bib40","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1007\/s12325-022-02131-3","article-title":"Is liver transplant curative in homozygous familial hypercholesterolemia? A review of nine global cases","volume":"39","author":"Al Dubayee","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib41","series-title":"Clinical Guidelines for Organ Transplantation from Deceased Donors","year":"2023"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2023.117305_bib42","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0740","article-title":"Progressive aortic stenosis in homozygous familial hypercholesterolemia after liver transplant","volume":"138","author":"Greco","year":"2016","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117305_bib43","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/ATVBAHA.107.160408","article-title":"Vascular calcifications in homozygote familial hypercholesterolemia","volume":"28","author":"Awan","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib44","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.atherosclerosis.2016.01.023","article-title":"The effect of statins on valve function and calcification in aortic stenosis: a meta-analysis","volume":"246","author":"Zhao","year":"2016","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2023.117305_bib45","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.amjcard.2014.01.414","article-title":"Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL)","volume":"113","author":"Arsenault","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117305_bib46","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.atherosclerosis.2015.01.007","article-title":"Impact of LDL apheresis on aortic root atheroma in children with homozygous familial hypercholesterolemia","volume":"239","author":"Lefort","year":"2015","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117305_bib47","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1010-7940(00)00456-5","article-title":"Aortic valve replacement for the calcified ascending aorta in homozygous familial hypercholesterolemia","volume":"18","author":"Yasuda","year":"2000","journal-title":"Eur. J. Cardio. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117305_bib48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejcts.2005.11.001","article-title":"Surgery for calcific aortic root stenosis in homozygous familial hypercholesterolemia","volume":"29","author":"Saito","year":"2006","journal-title":"Eur. J. Cardio. Thorac. Surg."},{"issue":"14","key":"10.1016\/j.atherosclerosis.2023.117305_bib49","first-page":"1159","article-title":"Surgical strategies for severe calcification of the aorta (porcelain aorta) in two patients with homozygous familial hypercholesterolemia","volume":"23","author":"Grenon","year":"2007","journal-title":"Can. J. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117305_bib50","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.athoracsur.2005.07.077","article-title":"Homograft replacement of the calcified aortic root in familial hypercholesterolemia","volume":"81","author":"Elghobary","year":"2006","journal-title":"Ann. Thorac. Surg."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117305_bib51","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00000658-198512000-00001","article-title":"Combined transplantation of the heart and liver","volume":"202","author":"Shaw","year":"1985","journal-title":"Ann. Surg."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib52","series-title":"ANZLITR 32nd Annual Report 2020","year":"2020"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2023.117305_bib53","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/eji.202048875","article-title":"Advances in Liver Transplantation: where are we in the pursuit of transplantation tolerance?","volume":"51","author":"Safinia","year":"2021","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117305_bib54","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S2213-8587(17)30044-X","article-title":"Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study","volume":"5","author":"Raal","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"48","key":"10.1016\/j.atherosclerosis.2023.117305_bib55","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1093\/eurheartj\/ehw388","article-title":"Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial","volume":"37","author":"Moriarty","year":"2016","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117305_bib56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jca.21839","article-title":"Lipoprotein apheresis and PCSK9 inhibitors for severe familial hypercholesterolaemia: experience from Australia and New Zealand","volume":"36","author":"Page","year":"2021","journal-title":"J. Clin. Apher."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2023.117305_bib57","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa2004215","article-title":"Evinacumab for homozygous familial hypercholesterolemia","volume":"383","author":"Raal","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib58","series-title":"Evkeeza (Evinacumab) Phase 3 Trial Demonstrates 48% LDL-C Reduction in Children with Ultra-rare Form of High Cholesterol: Regeneron","year":"2022"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2023.117305_bib59","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.5551\/jat.RV17065","article-title":"Advancements in the treatment of homozygous familial hypercholesterolemia","volume":"29","author":"Bajaj","year":"2022","journal-title":"J. Atherosclerosis Thromb."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117305_bib60","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/humc.2017.007","article-title":"Nonclinical pharmacology\/toxicology study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a mouse model of homozygous familial hypercholesterolemia","volume":"28","author":"Greig","year":"2017","journal-title":"Hum Gene Ther Clin Dev"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2023.117305_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013424","article-title":"Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis","volume":"5","author":"Kassim","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2023.117305_bib62","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020401118","article-title":"Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3","volume":"118","author":"Qiu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2023.117305_bib63","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/CIRCULATIONAHA.117.031335","article-title":"Reduced blood lipid levels with in vivo CRISPR-Cas9 base editing of ANGPTL3","volume":"137","author":"Chadwick","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106857","article-title":"Recent advances in the management and implementation of care for familial hypercholesterolaemia","volume":"194","author":"Lan","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2023.117305_bib65","doi-asserted-by":"crossref","first-page":"164","DOI":"10.18773\/austprescr.2016.060","article-title":"PCSK9 inhibitors\u2013mechanisms of action","volume":"39","author":"Page","year":"2016","journal-title":"Aust. Prescr."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117305_bib66","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jacl.2017.02.010","article-title":"Plasma lipoprotein(a) levels in patients with homozygous autosomal dominant hypercholesterolemia","volume":"11","author":"Sjouke","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117305_bib67","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jacl.2023.03.010","article-title":"Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: a cross-sectional study","volume":"17","author":"de Boer","year":"2023","journal-title":"J Clin Lipidol"},{"issue":"39","key":"10.1016\/j.atherosclerosis.2023.117305_bib68","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-023-00892-0","article-title":"International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia","author":"Watts","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.117305_bib70","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2018.06.859","article-title":"Familial hypercholesterolemia treatments: guidelines and new therapies","volume":"277","author":"Raal","year":"2018","journal-title":"Atherosclerosis"},{"issue":"3 Suppl","key":"10.1016\/j.atherosclerosis.2023.117305_bib71","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jacl.2014.02.011","article-title":"The national lipid association's statin safety task F. An assessment by the statin liver safety task force: 2014 update","volume":"8","author":"Bays","year":"2014","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117305_bib72","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5551\/jat.RV17029","article-title":"Liver transplantation for homozygous familial hypercholesterolemia","volume":"26","author":"Ishigaki","year":"2019","journal-title":"J. Atherosclerosis Thromb."},{"issue":"45","key":"10.1016\/j.atherosclerosis.2023.117305_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus Statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023052267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023052267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:53:27Z","timestamp":1758156807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915023052267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":73,"alternative-id":["S0021915023052267"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117305","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes of liver transplantation for homozygous familial hypercholesterolaemia in Australia and New Zealand","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117305"}}